FIELD: medicine.
SUBSTANCE: group of inventions relates to the use of triacetyl-3-hydroxyphenyladenosine represented by formula (I)
in the preparation of pharmaceutical preparations containing an effective amount of triacetyl-3-hydroxyphenyladenosine to reduce the number of circulating monocytes in a subject with hyperlipidemia. While the effective amount is in the range from 50 to 200 mg/kg of body weight.
EFFECT: inventions make it possible to significantly reduce the number of inflammatory mononuclear cells circulating in the blood of a subject with hyperlipidemia.
4 cl, 5 dwg, 3 tbl
| Title |
Year |
Author |
Number |
| METHODS FOR USE OF TRIACETYL-3-HYDROXYPHENYLADENOZINE IN TREATMENT OF INFLAMMATORY PROCESSES IN VESSELS OR IMPROVEMENT OF VESSEL ENDOTHELIUM FUNCTIONS |
2017 |
|
RU2783498C2 |
| APPLICATION OF NKG2D INHIBITORS FOR TREATING CARDIOVASCULAR AND METABOLIC DISEASES SUCH AS TYPE 2 DIABETES |
2010 |
- Sjun Na
- Sja Mintsan'
- Rolet Dehvid Kh.
- Petersen Jakob Sten
- Bedvarsdouttir Toura Brin'Ja
|
RU2566264C2 |
| USE OF TRIACETYL-3-HYDROXYPHENYLADENOSINE FOR THE PREPARATION OF PHARMACEUTICAL DRUG FOR THE PREVENTION OR TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE |
2016 |
|
RU2759916C2 |
| COMPOSITIONS WHICH POISSESS LIPID-REDUCING PROPERTIES |
2006 |
- Vest Sajmon Majkl
- Ogru Ehsra
- Libinaki Roksan
|
RU2428973C2 |
| PEPTIDE POSSESSING ABILITY TO RELIEVE AT LEAST ONE SYMPTOM OF INFLAMMATORY CONDITION, PHARMACEUTICAL COMPOSITION CONTAINING IT AND METHOD OF TREATING ATHEROSCLEROSIS WITH THEIR APPLICATION |
2005 |
- Anantkharamajakh Gattadakhalli M.
- Navab Mokhamad
- Fogelmehn Ehlan M.
|
RU2448977C2 |
| THERAPEUTIC AGENTS AND METHODS FOR THE TREATMENT OF TLR2-MEDIATED DISEASES AND DISORDERS |
2019 |
- Witztum, Joseph, L.
- Tsimikas, Sotirios
- Que, Xuchu
|
RU2791022C2 |
| COMPOSITIONS CONTAINING DPP-4 INHIBITOR FOR PREVENTION OR TREATMENT OF VALVE CALCIFICATION |
2015 |
- Chang, Eun-Ju
- Song, Jae-Kwan
- Kim, Mi Jeong
- Choi, Bongkun
- Lee, Sahmin
|
RU2680527C1 |
| USE OF 2,4-DIAMINOPYRIMIDINES FOR TREATING ATHEROSCLEROSIS |
2009 |
- Masuda Ehsteban
- Shmitts Jokhen
|
RU2490015C2 |
| OXIDISED LIPIDES AND USE THEREOF FOR TREATING INFLAMMATORY DISEASES AND DISORDERS |
2009 |
- Kharats Dror
- Dzhordzh Jakob
- Khal'Perin Gideon
- Jakov Niva
- Kovalevski-Ishai Ehti
|
RU2482854C2 |
| COMPOSITION OF TRADITIONAL CHINESE MEDICINE, METHOD OF ITS PREPARATION AND ITS USE |
2021 |
|
RU2806632C1 |
